Navigation Links
Genetics Influence Blood Pressure Medications
Date:1/22/2008

A person's gene profile seems to dictate reponse, study finds

TUESDAY, Jan. 22 (HealthDay News) -- A person's genetic make-up seems to influence how he or she reacts to certain hypertension medications.

In the future, being able to match genes with medications may help save a patient's life, experts predict.

"This is potentially a very, very important observation. It's a large study with hard clinical endpoints," said Dr. Joshua M. Hare, chief of cardiology at the University of Miami Miller School of Medicine. "This is a beautiful example of what we anticipate personalized medicine to be," said Hare, who was not involved in the research.

Another expert agreed. Dr. Jeffery Vance, professor at the Miami Institute for Human Genomics, said that "This is where medicine is going. It's important that we've got big clinical trials [showing this]. They cost a lot of money but this shows that it's clearly worth it."

The gene variant identified in the new study is likely to be just one of several that play a role in hypertension, also known as high blood pressure.

"Hypertension is such a complex disease. There are many different mechanisms that help us regulate our blood pressure so we would not expect any one gene to have a really large effect for [such] a common condition like hypertension," noted study senior author Donna K. Arnett, professor and chair of the University of Alabama at Birmingham's department of epidemiology. "That we found this effect is important because we didn't think we would ever be able to do pharmacogenetics, given the complexity of hypertension."

According to background information with the study, published in the Jan. 23 issue of the Journal of the American Medical Association, some 65 million people in the United States have hypertension. But only about two-thirds have their condition under control. Uncontrolled hypertension can lead to such problems as heart attack and stroke.

Previous studies have shown that the presence of certain gene characteristics can predict response to treatments such as ACE inhibitors, which are drugs used to control hypertension. But this information hasn't been adopted widely by doctors.

The new study focused on the NPPA (atrial natriuretic precursor A) gene, which is involved in forming atrial natriuretic polypeptide, which acts as a diuretic.

Specifically, the study authors wanted to see if people with hypertension and two different NPPA genotypes (known as NPPA G664A and NPPA T2238C) responded differently to different medications.

In all, 38,462 people with hypertension underwent genotyping [genetic testing] and were randomly assigned to receive a diuretic (chlorthalidone) or one of the following three drugs: a calcium channel blocker (amlodipine); an angiotensin converting enzyme inhibitor (lisinopril); or an alpha-blocker (doxazosin).

People with the more common subtype of the NPPA gene responded better to the calcium channel blocker than the diuretic. There were no differences in response between the diuretic and the other two drugs studied, the researchers said.

People with the other genotype fared better on the diuretic.

"Eventually we should be able to utilize prescreening for treatment to determine which drug you may respond best to," Arnett said. "This is a small but important step towards personalized medicine."

More information

The American Heart Association has more on high blood pressure.



SOURCES: Joshua M. Hare, M.D., chief of cardiology, University of Miami Miller School of Medicine; Jeffery Vance, M.D., Ph.D., professor, Miami Institute for Human Genomics; Donna K. Arnett, Ph.D., chair and professor, department of epidemiology, University of Alabama at Birmingham; Jan. 23, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. People with anorexia less likely to be blamed when biology, genetics explained
2. Top10 research advances include studies on genetics and stem cell research, stents
3. Heart attack risk from smoking due to genetics
4. Genetics May Boost Mexican-Americans Risk for Alcoholism
5. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
6. Researchers develop powerful tool to study the genetics of inflammation
7. deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference
8. deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference
9. Genetics and Risk, This Week on Your Cancer Today(TM)
10. CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development
11. Response Genetics Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetics Influence Blood Pressure Medications
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased ... a convenient service for Texas, they are expanding their presence in Dallas. One of ... spree that will bring new jobs to the Dallas and Forth Worth market. STAT ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged to ... mind, SIGVARIS has created a new line of anti-embolism stockings to help prevent ... the benefits of graduated compression when transitioning from recovery to early rehabilitation. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... AMSTERDAM , December 8, 2016 Information ... TM metrics in Scopus , the world,s largest ... free access to comprehensive metrics for journals from over 5,000 publishers. ... publish, which journals to subscribe to and when to adjust a ... , , ...
(Date:12/8/2016)... 2016 According to the research report, ... is expected to be worth US$9.7 bn by the ... Between the forecast years of 2016 and 2024, the global ... The leading players operating in the global diabetes injection pens ... plc., Biocon Ltd., and Sanofi S.A. Transparency Market Research reports ...
(Date:12/8/2016)... 2016 According to a new market research report ... Therapeutic (Pain, Insulin)), End Use (Sports, Fitness, RPM), Type (Smart watch, Patch), ... global market, in terms of value, is projected to reach 12.14 Billion ... 18.0% during the forecast period. Continue Reading ... ...
Breaking Medicine Technology: